NEUROTECH FUTURES • 119 implied HN points • 15 Apr 24
- Neurotech developments in April 2024 include significant funding for startups like Syntropic, Neurava, and Seaport Therapeutics.
- Commercial advancements in neurotechnology involve companies like Synchron, NeuroOne, and Cognito Therapeutics launching new products and making significant progress in their fields.
- Regulatory updates show clearances for devices by FDA, submissions like ONWARD Medical's De Novo Application, and the importance of FDA approvals in the neurotech industry.